Avior Wealth Management’s Anika Therapeutics ANIK Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-3	Closed	-$76	–	2331
2024 Q1	$76	Buy	+3	New	+$73	﹤0.01%	3303
2022 Q3	–	Hold	0	–	–	–	1145
2022 Q2	–	Sell	-9,436	Closed	-$211K	–	1055
2022 Q1	$236K	Sell	9,436 -1,872	-17%	-$57.1K	0.02%	412
2021 Q4	$405K	Hold	11,308	–	–	0.03%	356
2021 Q3	$481K	Hold	11,308	–	–	0.04%	323
2021 Q2	$489K	Sell	11,308 -2,028	-15%	-$86.4K	0.05%	302
2021 Q1	$543K	Buy	13,336 +252	+2%	+$9.56K	0.06%	281
2020 Q4	$592K	Hold	13,084	–	–	0.07%	228
2020 Q3	$463K	Buy	13,084 +1,855	+17%	+$67K	0.07%	247
2020 Q2	$423K	Hold	11,229	–	–	0.07%	263
2020 Q1	$324K	Hold	11,229	–	–	0.06%	261
2019 Q4	$582K	Hold	11,229	–	–	0.09%	210
2019 Q3	$616K	Sell	11,229 -2,077	-16%	-$107K	0.11%	182
2019 Q2	$540K	Hold	13,306	–	–	0.1%	195
2019 Q1	$402K	Buy	13,306 +3,731	+39%	+$128K	0.09%	236
2018 Q4	$321K	Hold	9,575	–	–	0.08%	236
2018 Q3	$404K	Hold	9,575	–	–	0.09%	216
2018 Q2	$306K	Buy	9,575 +1,000	+12%	+$41.2K	0.07%	245
2018 Q1	$426K	Hold	8,575	–	–	0.1%	187
2017 Q4	$462K	Buy	+8,575	New	+$475K	0.1%	185